Adoptive Transfer of NY-ESO-1 TCR Engineered Peripheral Blood Mononuclear Cells (PBMC) and Peripheral Blood Stem Cells (PBSC) After a High Dose Melphalan Conditioning Regimen, With Administration of Interleukin-2, in Patients With Multiple Myeloma
Investigator(s):
Sarah Larson, M.D.
Organization:
UCLA
NCT Number:
Disease Name:
Multiple Myeloma
Disease Category:
Trial Phases:
Phase 1
Trial Status:
Closed
Antoni Ribas, M.D., Ph.D.
Trial Contact:
Ignacio Baselga Carretero, Ph.D.
(310) 206-2090
IBaselga@mednet.ucla.edu
